Metabolic biomarker development creating strategy — ACSL1 expression and lipid metabolism biomarkers enabling patient stratification identifying ACSL1-dependent cancers likely to respond to ACSL1-targeted therapy optimizing treatment selection and predicting therapeutic response, with the ACSL1 Antibody Market positioned for transformation where biomarker-driven approach enables precision...